Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma

Abstract

We identified a 35-gene signature that identifies high-risk and low-risk categories of 1p/19q positive glioma patients. We have demonstrated heterogeneity amongst a relatively new glioma subtype and provided a stepping stone towards risk stratification.